Poolbeg Pharma Ltd. (GB:POLB)
LSE:POLB

Poolbeg Pharma Ltd. (POLB) Financial Statements

14 Followers

Poolbeg Pharma Ltd. Financial Overview

Poolbeg Pharma Ltd.'s market cap is currently ―. The company's EPS TTM is p-0.007; its P/E ratio is -16.81; Poolbeg Pharma Ltd. is scheduled to report earnings on September 3, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22
Income Statement-
Total Revenue--
Gross Profit--
EBIT--
EBITDA--
Net Income Common Stockholders--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 16.19M£ 18.89M
Total Assets£ 19.29M£ 22.01M
Total Debt£ 0.00£ 0.00
Net Debt£ -16.19M£ -18.89M
Total Liabilities£ 966.00K£ 827.00K
Stockholders Equity£ 18.32M£ 21.19M
Cash Flow-
Free Cash Flow--
Operating Cash Flow--
Investing Cash Flow--
Financing Cash Flow--
Currency in GBP

Poolbeg Pharma Ltd. Earnings and Revenue History

Poolbeg Pharma Ltd. Debt to Assets

Poolbeg Pharma Ltd. Cash Flow

Poolbeg Pharma Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis